SIMULECT 20mg I.V. Price

Overview

Welcome to Dwaey, specifically on SIMULECT 20mg I.V. Injection page.
This medicine contains an important and useful components, as it consists of Basiliximab.
SIMULECT 20mg I.V. is available in the market in concentration 20mg/Vial and in the form of Injection.

NOVARTIS PHARMA AG is the producer of SIMULECT 20mg I.V. and it is imported from SWITZERLAND, The most popular alternatives of SIMULECT 20mg I.V. are listed downward .

Mode Of Action

Basiliximab, a chimeric murine/human monoclonal antibody, blocks the ?-chain of the interleukin-2 receptor complex on the surface of activated T-lymphocytes.

Indication

• Acute graft rejection in renal transplantation

Precaution

Pregnancy and lactation. Re-exposure to a subsequent course of therapy of basiliximab. Lactation: Unknown whether excreted in milk; because of the potential for adverse reactions, a decision should be made to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Side Effects

• Peripheral oedema
• hypertension
• atrial fibrillation; fever
• headache
• insomnia
• pain; wound complication
• acne; hypokalaemia
• hyperglycaemia
• hyperuricaemia
• hypophosphataemia
• hypercholesterolaemia; GI effects; UTI; anaemia; tremor; dyspnoea
• infection. Rarely
• hypersensitivity and anaphylactoid-type reactions.

Contra indication

Hypersensitivity to basiliximab and murine proteins.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.